The high mobility group A2 (HMGA2), an oncofetal protein, was shown to play a role in tumor development and progression. However, the molecular and clinical role of HMGA2 in epithelial ovarian carcinomas (EOCs) is still unknown. In the present study, EOC cell line SKOV3 was subjected to in vitro assays. Here, our findings showed that HMGA2 was highly expressed in EOC cell line SKOV3. HMGA2 knockdown promoted cell apoptosis and the cleavage of caspase 3, and decreased the B cell lymphoma 2 (Bcl-2)/Bax ratio in SKOV3. Functionally, HMGA2 knockdown resulted in reduction of SKOV3 cell migration and invasion. Mechanically, HMGA2 knockdown affected the occurrence of EMT by increasing E-cadherin gene and protein expression and decreasing the gene and protein expression of N-cadherin, slug, and vimentin. At the same time, HMGA2 also repressed the expression of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9), which was consistent with the decreased invasion capacity. In conclusion, HMGA2 is associated with migration and invasiveness and regulates the progression of EMT in the development of EOC, and HMGA2 gene and protein may be a novel therapeutic target against EOC in the clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13277-015-3852-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation.
PLoS One
November 2024
Department of Geriatrics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
The molecular mechanisms underlying hepatocellular carcinoma (HCC) are complex and not fully understood. This study aims to explore the expression and clinical significance of High Mobility Group (HMG) proteins in HCC to identify potential prognostic biomarkers and therapeutic targets. Bioinformatic analyses were performed using data from The Cancer Genome Atlas (TCGA) and other databases.
View Article and Find Full Text PDFEIF4A3-induced circle RNA_ 0001860 promotes growth, invasion, and immune evasion of gastric cancer cells through the miR-618/HMGA2 axis.
Neoplasma
October 2024
Department of Abdominal Radiotherapy, Harbin Medical University Cancer Hospital, Heilongjiang, China.
Article Synopsis
- Gastric cancer has a poor prognosis and circRNA_0001860 (circ_0001860) is found to be upregulated in gastric cancer cells, which may indicate its role in cancer development.
- Experiments showed that knocking down circ_0001860 decreased cell viability, invasion, and altered immune response in gastric cancer cells, suggesting it promotes cancer progression.
- The findings also suggest that circ_0001860 operates by sponging miR-618 and regulating HMGA2 levels, and its expression is influenced by EIF4A3, highlighting its potential as a therapeutic target.
HMGA2 regulates GPX4 expression and ferroptosis in prostate cancer cells.
Biochem Biophys Res Commun
December 2024
Center for Urban Health Disparities Research and Innovation, Department of Biology, Morgan State University, Baltimore, MD, 21251, USA. Electronic address:
Prostate cancer (PCa) remains a significant global health burden and an increase in oxidative stress is associated with cancer progression. High Mobility Group A2 (HMGA2), a chromatin architectural protein, increases oxidative stress and promotes sensitivity to ferroptosis inducers, however, the mechanism is unknown. We investigated the role of HMGA2 in GPX4 regulation and the impact on cellular responses to oxidative stress and ferroptosis sensitivity.
View Article and Find Full Text PDFExpression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer.
World J Gastrointest Oncol
August 2024
Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, Anhui Province, China.
Article Synopsis
- Gastric cancer (GC) is a prevalent malignant tumor, and the study investigates the role of CASC19, a new biomarker, in promoting tumor invasion and metastasis via its interaction with miR-491-5p and HMGA2.
- The research involved analyzing clinical samples and various cellular assays to understand how inhibiting CASC19 affects GC cell functions such as proliferation and invasion, as well as to clarify the regulatory relationships between CASC19, miR-491-5p, and HMGA2.
- Results indicated that CASC19 is linked to tumor progression factors, and its knockdown suppresses GC cell growth and promotes apoptosis, while miR-491-5p can inhibit GC cell proliferation and EMT
High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells.
Cancers (Basel)
July 2024
Center for Urban Health Disparities Research and Innovation, Department of Biology, Morgan State University, Baltimore, MD 21251, USA.
Metastatic prostate cancer (mPCa) is a leading cause of mortality, partly due to its resistance to anti-androgens like enzalutamide. Snail can promote this resistance by increasing full-length AR and AR-V7. High Mobility Group AT-hook 2 (HMGA2), a DNA-binding protein upstream of Snail, is crucial in proliferation and epithelial-mesenchymal transition (EMT).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!